Docker Containers in Medical Devices: FDA
Where containers appear in medical devices, the testing the FDA expects under the Feb 3, 2026 guidance, and how container evidence maps to eSTAR v7.0.
Read articleEvery article in our archive tagged eSTAR.
Showing 8 of 8 articles tagged eSTAR
Where containers appear in medical devices, the testing the FDA expects under the Feb 3, 2026 guidance, and how container evidence maps to eSTAR v7.0.
Read article
0 cybersecurity slots are identical for IVD and nIVD submissions, but the content reviewers expect is not.
Read article
What the FDA's Feb 2026 guidance expects in interoperability labeling for connected medical devices, what content goes in user docs, where it sits in.
Read article
How to design penetration test cases from a medical device threat model, the methodology that bridges STRIDE-style threats and concrete bench test.
Read article
What the FDA's Feb 2026 guidance expects in the unresolved cybersecurity anomalies assessment, how to document residual risk, and the deficiency pattern.
Read article
Section 524B(b)(1) makes patchability statutory. What the FDA's Feb 2026 guidance expects in the patch and update mechanism test evidence, the test cases.
Read article
DAST is a subset of FDA-required penetration testing. What the Feb 2026 guidance expects in eSTAR Slot 7, why a Burp scan alone fails review, and how to.
Read article
What FDA reviewers expect in eSTAR Section Q: SBOM, threat model, SPDF evidence, pen test reports, and a traceability matrix that survives RTA screening.
Read article30-minute strategy session. No cost, no commitment - just answers from people who've shipped 250+ FDA submissions.